ZIOPHARM Oncology, Inc. (ZIOP) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Net income (loss): -10.85M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income (loss): -10.85M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q2 EPS of ($0.06), $0.07 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $2.63 million.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
